Development of Analogues of 1α,25-Dihydroxyvitamin D3 with Biased Side-Chain Orientation: C20 Methylated Des-C,D-homo Analogues
✍ Scribed by Freek Vrielynck; Dirk Van Haver; Maurits Vandewalle; Lieve Verlinden; Annemieke Verstuyf; Roger Bouillon; Gianluca Croce; Pierre De Clercq
- Book ID
- 102828502
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 681 KB
- Volume
- 2009
- Category
- Article
- ISSN
- 1434-193X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The discovery that 1α,25‐dihydroxyvitamin D~3~ is effective in the inhibition of cellular proliferation and in the induction of cellular differentiation has led to a search for analogues in which these activities and the classical calcemic activity of the hormone are dissociated. In this context, the synthesis and biological evaluation are reported for six CD‐ring modified structural analogues that were conceived so as to enforce a particular orientation of the 25‐hydroxylated side chain. The analogues are characterized by the absence of the C‐ring and the presence of an unnatural six‐membered D‐ring. The biased side‐chain orientations are realized through the stereocontrolled incorporation of methyl substituents at positions C13/C20 and C16/C20. Comparison of the results of the biological evaluation and conformational analysis of the side chain confirms the existence of a relationship between inhibition of MCF‐7 breast cancer cell proliferation and side chain geometry.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v
The nuclear hormone 1a,25-dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 ) acts through the transcription factor vitamin D receptor (VDR) via combined contact with the retinoid X receptor (RXR), coactivator proteins, and speci®c DNA binding sites (VDREs). Ligand-mediated conformational changes of the VDR are
## Abstract An improved synthetic route to 1α,25‐dihydroxyvitamin D~3~ des‐side chain analogues **2 a** and **2 b** with substituents at C18 is reported, along with their biological activity. These analogues display significant antiproliferative effects toward MCF‐7 breast cancer cells and prodiffe